|Articles|May 27, 2016
Valeant Rejected Takeda Bid
May 27, 2016.
Advertisement
Reuters reports that Valeant Pharmaceuticals rejected a joint takeover offer from Japan's Takeda and TPG Capital Management this spring.
The offer was reportedly made a few weeks before Joseph Papa took over as Valeant's new chief executive in April.
More on the story
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
The Agentic AI Revolution in Biopharma
3
340B Under Pressure: Inside Pharma's Push for Greater Clarity
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5